Standard Biotools (LAB) Total Debt (2010 - 2024)

Standard Biotools (LAB) has 7 years of Total Debt data on file, last reported at $54.8 million in Q2 2024.

• On a quarterly basis, Total Debt rose 427.17% year-over-year to $54.8 million in Q2 2024; TTM through Jun 2024 was $54.8 million, a 427.17% increase from a year earlier, with the FY2023 full-year figure at $8.4 million, down 18.13% from the prior year.
• Total Debt for Q2 2024 stood at $54.8 million, up from $8.4 million in the prior quarter.
• Over the last five years, Total Debt for LAB reached as high as $54.8 million in Q2 2024 and fell as low as $8.4 million in Q4 2023.
• Historically, Total Debt has averaged $14.0 million across 4 years, with a median of $10.2 million in 2022.
• Across the five-year window, Total Debt retreated 18.13% in 2023 and surged 427.17% in 2024, its largest moves.
• Year by year, Total Debt stood at $10.0 million in 2021, then increased by 2.27% to $10.3 million in 2022, then dropped by 18.13% to $8.4 million in 2023, then jumped by 551.09% to $54.8 million in 2024.
• Per Business Quant data, the three most recent Total Debt figures were $54.8 million in Q2 2024, $8.4 million in Q4 2023, and $9.6 million in Q3 2023.